Literature DB >> 24346809

The impact of modern treatment principles may have eliminated lithium-induced renal failure.

Harald Aiff1, Per-Ola Attman, Mattias Aurell, Hans Bendz, Staffan Schön, Jan Svedlund.   

Abstract

We have previously shown that lithium can cause end-stage renal disease (ESRD): however, this serious side-effect of lithium in prophylactic treatment of mood disorders may reflect the treatment regime of the 1960s and 1970s. Today's modern treatment routines, intended to reduce or eliminate lithium-induced ESRD (Li-ESRD), were introduced in Sweden in the early 1980s. The aim of the present study was to test the hypothesis that these routines have eliminated the risk of Li-ESRD. We used the Swedish Renal Registry to identify patients on renal replacement therapy (RRT), treated with dialysis or renal transplantation, with suspected Li-ESRD in two regions of Sweden with altogether about three million inhabitants. We reviewed their medical records to verify the exposure to lithium treatment, the diagnosis of Li-ESRD and the date of starting the lithium treatment. We found 32 RRT patients in whom lithium treatment was the sole or main contributing cause of ESRD. The starting year of their lithium treatment was between 1965-1980 in all patients. No patient started lithium treatment later than 1980. Modern lithium treatment may have eliminated the risk of Li-ESRD. Our findings support the continued use of lithium as a safe drug for the long-term treatment of mood disorders.

Entities:  

Keywords:  Affective disorders; adverse effects; chronic kidney failure; lithium

Mesh:

Substances:

Year:  2013        PMID: 24346809     DOI: 10.1177/0269881113516202

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  10 in total

1.  Every reason to discontinue lithium.

Authors:  Manuel E Fuentes Salgado; Bruce Sutor; Robert C Albright; Mark A Frye
Journal:  Int J Bipolar Disord       Date:  2014-11-08

Review 2.  Chronic kidney disease in lithium-treated older adults: a review of epidemiology, mechanisms, and implications for the treatment of late-life mood disorders.

Authors:  Soham Rej; Dominique Elie; Istvan Mucsi; Karl J Looper; Marilyn Segal
Journal:  Drugs Aging       Date:  2015-01       Impact factor: 3.923

3.  Psychotropic Drugs and Adverse Kidney Effects: A Systematic Review of the Past Decade of Research.

Authors:  Joseph Junior Damba; Katie Bodenstein; Paola Lavin; Jessica Drury; Harmehr Sekhon; Christel Renoux; Emilie Trinh; Soham Rej; Kyle T Greenway
Journal:  CNS Drugs       Date:  2022-09-26       Impact factor: 6.497

Review 4.  Lithium in the Kidney: Friend and Foe?

Authors:  Mohammad Alsady; Ruben Baumgarten; Peter M T Deen; Theun de Groot
Journal:  J Am Soc Nephrol       Date:  2015-11-17       Impact factor: 10.121

5.  Lithium nephrotoxicity.

Authors:  Abed N Azab; Alla Shnaider; Yamima Osher; Dana Wang; Yuly Bersudsky; R H Belmaker
Journal:  Int J Bipolar Disord       Date:  2015-06-05

6.  Does long term use of psychiatric drugs cause more harm than good?

Authors:  Peter C Gøtzsche; Allan H Young; John Crace
Journal:  BMJ       Date:  2015-05-12

Review 7.  Lithium side effects and toxicity: prevalence and management strategies.

Authors:  Michael Gitlin
Journal:  Int J Bipolar Disord       Date:  2016-12-17

8.  Drug information update. Lithium and chronic kidney disease: debates and dilemmas.

Authors:  Sumeet Gupta; Udayan Khastgir
Journal:  BJPsych Bull       Date:  2017-08

Review 9.  Lithium and nephrotoxicity: a literature review of approaches to clinical management and risk stratification.

Authors:  J Davis; M Desmond; M Berk
Journal:  BMC Nephrol       Date:  2018-11-03       Impact factor: 2.388

10.  Lithium rechallenge after renal transplant.

Authors:  Anna K Beasley; Catherine C Larson; Erica C Garcia-Pittman
Journal:  Ment Health Clin       Date:  2018-03-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.